Meta-analysis of 5 RCTs (13,245 patients with recent myocardial infarction): colchicine vs placebo did not significantly reduce MACE (8.2% vs 9.3%; RR 0.83, 95% CI 0.66-1.04) and did not increase adverse events.
Meta-analysisn = 13,245
Moiz et al. Colchicine in Patients With Recent Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials